Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor

Abstract The rapid structural evolution and emergence of novel synthetic cannabinoid receptor agonists (SCRAs) in the recreational market remains a key public health concern. Despite representing one of the largest classes of new psychoactive substances, pharmacological data on new SCRAs is limited,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Monica Patel, Natasha L. Grimsey, Samuel D. Banister, David B. Finlay, Michelle Glass
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-12-01
coleção:	Pharmacology Research & Perspectives
Assuntos:	agonist bias cannabinoid CB2 receptor cell signaling synthetic cannabinoid receptor agonist THC
Acesso em linha:	https://doi.org/10.1002/prp2.1157
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!